继发性脉络膜新生血管——真的那么普遍吗？］

Die Ophthalmologie Pub Date : 2025-03-01 Epub Date: 2025-02-10 DOI:10.1007/s00347-025-02197-8

Ulrike Brocks, Martin Ziegler, Clemens Lange, Lebriz Altay, Laurenz Pauleikhoff

{"title":"继发性脉络膜新生血管——真的那么普遍吗？］","authors":"Ulrike Brocks, Martin Ziegler, Clemens Lange, Lebriz Altay, Laurenz Pauleikhoff","doi":"10.1007/s00347-025-02197-8","DOIUrl":null,"url":null,"abstract":"The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"196-200"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Secondary choroidal neovascularization-Really so common?]\",\"authors\":\"Ulrike Brocks, Martin Ziegler, Clemens Lange, Lebriz Altay, Laurenz Pauleikhoff\",\"doi\":\"10.1007/s00347-025-02197-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.\",\"PeriodicalId\":72808,\"journal\":{\"name\":\"Die Ophthalmologie\",\"volume\":\" \",\"pages\":\"196-200\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Die Ophthalmologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00347-025-02197-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Ophthalmologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00347-025-02197-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

继发性脉络膜新生血管（CNV）的发生是慢性中枢性浆液性脉络膜视网膜病变患者的并发症。诊断采用多模态成像。治疗通常包括玻璃体内注射抗血管内皮生长因子（VEGF）。结合光动力疗法是有用的；然而，与CNV的其他适应症相比，抗vegf治疗的反应明显降低，因此视力往往会出现不可逆的下降。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Secondary choroidal neovascularization-Really so common?]

The occurrence of secondary choroidal neovascularization (CNV) is a complication in patients with chronic central serous chorioretinopathy. The diagnosis is made using multimodal imaging. The treatment usually includes intravitreal anti-vascular endothelial growth factor (VEGF) injections. A combination with photodynamic therapy can be useful; however, the response to anti-VEGF treatment is significantly reduced compared to other indications for CNV, so that an irreversible decrease of visual acuity often remains.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Die Ophthalmologie

自引率

0.00%

发文量